Author details

Full Name

Andrew G Sikora

Affiliation

ORCID

Career Start Year

1998

Papers

163

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37487414	GWAS-identified telomere length associated genetic variants predict risk of recurrence of HPV-positive oropharyngeal cancer after definitive radiotherapy.	EBioMedicine	2023
36378845	Immunogenetic Determinants of Susceptibility to Head and Neck Cancer in the Million Veteran Program Cohort.	Cancer Research	2023
37604640	<i>TP53</i> gain-of-function mutation modulates the immunosuppressive microenvironment in non-HPV-associated oral squamous cell carcinoma.	J Immunother Cancer	2023
37572314	The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapies.	J Natl Cancer Inst	2023
36702015	Human papillomavirus status and prognosis of oropharyngeal high-grade neuroendocrine carcinoma.		2023
37190274	Association of Suppressive Myeloid Cell Enrichment with Aggressive Oropharynx Squamous Cell Carcinoma.	Cancers (Basel)	2023
36939627	Comparative Treatment Outcomes for Idiopathic Subglottic Stenosis: 5-Year Update.	Otolaryngol Head Neck Surg	2023
37183412	Enhancement of Immunotherapies in Head and Neck Cancers Using Biomaterial-Based Treatment Strategies.	Tissue Eng Part C Methods	2023
37178654	Characterization of the oral microbiota among middle-aged men with and without human papillomavirus infection.		2023
34808012	Oral squamous cell carcinoma outcome in adolescent/young adult: Systematic review and meta-analysis.	Head and Neck	2022
35902768	Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma.	Commun Biol	2022
35697909	In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts.	J Mammary Gland Biol Neoplasia	2022
35881233	Correction to: In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts.	J Mammary Gland Biol Neoplasia	2022
36002187	Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor response.	J Immunother Cancer	2022
36335817	Mildly dysplastic oral lesions with optically-detectable abnormalities share genetic similarities with severely dysplastic lesions.	Oral Oncol	2022
36066461	Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.	Cancer	2022
35867552	Risk and incidence of head and neck cancers in veterans living with HIV and matched HIV-negative veterans.	Cancer	2022
36514351	Hypermethylation of <i>nc886</i> in HPV-positive oropharyngeal cancer and its clinical implications: An epigenome-wide association study.	Mol Ther Nucleic Acids	2022
36643309	Characterizing treatment resistance in muscle invasive bladder cancer using the chicken egg chorioallantoic membrane patient-derived xenograft model.		2022
35175599	The Chicken Embryo Chorioallantoic Membrane (CAM): A Versatile Tool for the Study of Patient-Derived Xenografts.	Methods in Molecular Biology	2022
35184149	Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration.	Mod Pathol	2022
35286200	Lysosomal inhibition sensitizes TMEM16A-expressing cancer cells to chemotherapy.	Proc Natl Acad Sci U S A	2022
35154165	Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy.	Frontiers in Immunology	2022
34411638	Prospective Clinical Investigation of the Efficacy of Combination Radiation Therapy With Immune Checkpoint Inhibition.	International Journal of Radiation Oncology Biology Physics	2021
34021022	Local Anti-PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model.	Cancer Prev Res (Phila)	2021
34230113	Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects.	Journal for ImmunoTherapy of Cancer	2021
33629608	Association of Social Determinants of Health with Time to Diagnosis and Treatment Outcomes in Idiopathic Subglottic Stenosis.	Ann Otol Rhinol Laryngol	2021
33470801	Biomaterial-Facilitated Immunotherapy for Established Oral Cancers.	ACS Biomaterials Science and Engineering	2021
33675133	De-Escalated Adjuvant Therapy After Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Carcinoma: The Sinai Robotic Surgery (SIRS) Trial.	Oncologist	2021
34262645	Esomeprazole enhances the effect of ionizing radiation to improve tumor control.	Oncotarget	2021
33827904	Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?	J Immunother Cancer	2021
33660372	Human epidermal growth factor receptor 2 expression in head and neck squamous cell carcinoma: Variation within and across primary tumor sites, and implications for antigen-specific immunotherapy.	Head and Neck	2021
33651718	Computerized tumor multinucleation index (MuNI) is prognostic in p16+ oropharyngeal carcinoma.	J Clin Invest	2021
33048407	The role of human papillomavirus in the pathogenesis of sinonasal inverted papilloma: a narrative review.	Reviews in Medical Virology	2021
32988279	Biomarkers for Malignant Potential in Vocal Fold Leukoplakia: A State of the Art Review.	Otolaryngol Head Neck Surg	2021
33417831	Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.	Cancer Cell	2021
32603507	The Proximal Airway Is a Reservoir for Adaptive Immunologic Memory in Idiopathic Subglottic Stenosis.	Laryngoscope	2021
31383940	Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.	Oncogene	2020
32269052	Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8 Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results.	Clinical Cancer Research	2020
32145203	Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors.	Molecular Therapy	2020
31648864	Innovations in risk-stratification and treatment of Veterans with oropharynx cancer; roadmap of the 2019 Field Based Meeting.	Oral Oncol	2020
31937831	CD8 infiltration is associated with disease control and tobacco exposure in intermediate-risk oropharyngeal cancer.	Sci Rep	2020
31670805	Comparative Treatment Outcomes for Patients With Idiopathic Subglottic Stenosis.	JAMA Otolaryngol Head Neck Surg	2020
32286489	High expression of oxidative phosphorylation genes predicts improved survival in squamous cell carcinomas of the head and neck and lung.	Sci Rep	2020
32214199	Correction: UDP-glucose 6-dehydrogenase regulates hyaluronic acid production and promotes breast cancer progression.	Oncogene	2020
32768727	Neovascularized implantable cell homing encapsulation platform with tunable local immunosuppressant delivery for allogeneic cell transplantation.	Biomaterials	2020
32820250	Correction: Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.	Oncogene	2020
33094910	Incidence and survival for oropharynx and non-oropharynx head and neck cancers among veterans living with HIV.	Cancer Med	2020
32523042	In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation.	Scientific Reports	2020
33229578	A steroid receptor coactivator stimulator (MCB-613) attenuates adverse remodeling after myocardial infarction.	Proc Natl Acad Sci U S A	2020